McKesson Corp. (MCK) , the drug distributor, has been getting plenty of attention with the roll out of the Covid-19 vaccines. We looked in on MCK back on December 18 (https://realmoney.thestreet.com/investing/stocks/mckesson-s-rally-has-further-to-go-15521329) where we wrote, "Continue to hold longs on MCK recommended in November risking a close below $165. Our longer-term price targets lie in the $225-$250 area."
What do the charts look like now?
(For more on MCK, see Jim Cramer: Here's My Plan to Distribute the Vaccine)